Population
104 surgically treated patients with synovial sarcoma without metastases at diagnosis from the Scandinavian…
Design
Cohort
Follow-up
up to 7 years
Authors
Loading...
These factors may aid risk stratification in synovial sarcoma; leaves open whether they guide therapy without prospective validation.
In patients with synovial sarcoma, large tumor size, local recurrence, histologic Grade IV, high MIB1 index, and SYT-SSX1 fusion transcript are significant prognostic factors for impaired metastasis-free survival.
Björn Skytting (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: